schisandra chinensis
Selected indexed studies
- Schisandra chinensis and its phytotherapeutical applications. (Ceska Slov Farm, 2019) [PMID:31431019]
- Vinegar-processed Schisandra Chinensis enhanced therapeutic effects on colitis-induced depression through tryptophan metabolism. (Phytomedicine, 2024) [PMID:39357281]
- Schisandra chinensis mixture attenuates diabetic kidney disease via VDAC1/Grp75/IP(3)R-mediated MAMs stabilization and apoptosis-autophagy regulation. (Phytomedicine, 2025) [PMID:40857962]
_Worker-drafted node — pending editorial review._
Connections
schisandra chinensis helps
Sources
- Vinegar-processed Schisandra Chinensis enhanced therapeutic effects on colitis-induced depression through tryptophan metabolism. (2024) pubmed
- Schisandra chinensis and its phytotherapeutical applications. (2019) pubmed
- Protective effect of acidic polysaccharide from Schisandra chinensis on acute ethanol-induced liver injury through reducing CYP2E1-dependent oxidative stress. (2018) pubmed
- Schisandra chinensis Fructus and Its Active Ingredients as Promising Resources for the Treatment of Neurological Diseases. (2018) pubmed
- Schisandra chinensis lignans ameliorate hepatic inflammation and steatosis in methionine choline-deficient diet-fed mice by modulating the gut-liver axis. (2025) pubmed
- Cardioprotective Potential of Berries of Schisandra chinensis Turcz. (Baill.), Their Components and Food Products. (2023) pubmed
- Integrated UPLC-ESI-MS/MS, network pharmacology, and transcriptomics to reveal the material basis and mechanism of Schisandra chinensis Fruit Mixture against diabetic nephropathy. (2024) pubmed
- Schisandra chinensis mixture attenuates diabetic kidney disease via VDAC1/Grp75/IP(3)R-mediated MAMs stabilization and apoptosis-autophagy regulation. (2025) pubmed
- A comprehensive review of ethnopharmacology, phytochemistry, pharmacology, and pharmacokinetics of Schisandra chinensis (Turcz.) Baill. and Schisandra sphenanthera Rehd. et Wils. (2022) pubmed
- Lignans of Schisandra chinensis (Turcz.) Baill inhibits Parkinson's disease progression through mediated neuroinflammation-TRPV1 expression in microglia. (2024) pubmed